Biogen (BIIB) Divestments (2009 - 2025)

Biogen (BIIB) posted quarterly Divestments of $56.7 million for Q4 2025, down 94.27% quarter-over-quarter from $990.3 million in Q2 2022.

Biogen (BIIB) Divestments (2009 - 2025) Analysis & Trends

Biogen's Divestments history runs 5 years deep, the most recent figure standing at $56.7 million for Q4 2025.

In Q4 2025, Divestments changed N/A year-over-year to $56.7 million; the TTM figure through Dec 2025 stood at $56.7 million (changed N/A YoY), while the FY2025 annual figure was $56.7 million, down 86.06% from the prior year.
Divestments for Q4 2025 stood at $56.7 million, down from $990.3 million in the prior quarter.
The five-year high for Divestments was $990.3 million in Q2 2022, with the low at -$63.1 million in Q2 2021.
The 3-year median for Divestments is $65.4 million (2021), against an average of $228.1 million.
Peak annual rise in Divestments reached 1669.41% in 2022, while the deepest fall reached 1669.41% in 2022.
Biogen's Divestments stood at $65.4 million in 2021, then soared by 1414.22% to $990.3 million in 2022, then tumbled by 94.27% to $56.7 million in 2025.
Business Quant data shows BIIB's Divestments at $56.7 million in Q4 2025, $990.3 million in Q2 2022, and $65.4 million in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Divestments (Qtr)
1	Johnson & Johnson	652.20 Bn	631.44 Bn	17.26 Bn	-
2	AbbVie	469.51 Bn	462.94 Bn	12.70 Bn	-
3	Merck	376.81 Bn	369.67 Bn	12.21 Bn	-
4	Novartis Ag	303.04 Bn	295.35 Bn	11.24 Bn	62.00 Mn
5	Astrazeneca	257.61 Bn	252.71 Bn	12.86 Bn	-
6	Amgen	237.37 Bn	223.38 Bn	7.24 Bn	-
7	Gilead Sciences	181.73 Bn	178.55 Bn	6.22 Bn	-
8	Pfizer	159.66 Bn	147.96 Bn	10.94 Bn	1.88 Bn
9	Gsk	106.24 Bn	102.07 Bn	8.24 Bn	-
10	Biogen	32.04 Bn	30.76 Bn	1.96 Bn	-

Download Data